Skip to content

Comparison of using corticosteroids metered dose inhaler with or without spacer

Comparison of using corticosteroids metered dose inhaler with or without spacer in patients without coordination problems with uncontrolled or poorly controlled asthma, a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230731058982N1
Enrollment
114
Registered
2023-08-12
Start date
2023-08-21
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Asthma

Interventions

Intervention 1: Intervention group: Spacer group: A free-of-cost spacer is given to the patient to attach it to his corticosteroid spray, and take his ICS with the spacer for six weeks from the interv

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults over 18 to 65 years old with uncontrolled or poorly controlled asthma (ACT score < 20) Using corticosteroid inhalers in the form of MDI (metered dose inhaler) for at least three months before starting the study and being adherent to treatments Not Having a critical error when using inhalation spray

Exclusion criteria

Exclusion criteria: Suffering from any tremors, Parkinson's, or using medications that cause tremors continuously Neuro-cognitive problems that lead to incorrect use of the inhaler by the patient. Not consented to include in the trial

Design outcomes

Primary

MeasureTime frame
Asthma Control Test (ACT). Timepoint: Six weeks. Method of measurement: Asthma Control Test questionnaire.;Spirometry indexes including FEV1? FVC? FEV1/FVC. Timepoint: before intervention and 6 weeks after intervention. Method of measurement: Spirometry.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloofar Khoshnam-Rad

Tehran University of Medical Sciences

kh.niloofar@gmail.com+98 21 6119 2644

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026